About David Waddell
Form D filings for Calosyn Pharma from 2009 to 2024 list David Waddell as director.
David Waddell first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name David Waddell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Waddell works with at each company, as listed on that company's latest Form D.
Calosyn Pharma, Inc. · Form D, Mar 7, 2024
JL
Joseph Lovett
Director
RB
Richard Babb
Treasurer and director
RB
Ross Barrett
Secretary and director
WG
William Grimes
President and Chief Executive Officer, director